State Street Portfolio holdings
State Street Corporation, established in 1792 and headquartered in Boston, Massachusetts, is one of the oldest financial institutions in the United States and a major player in the global asset management and custody banking sectors. Primarily known for its custodial services, it safeguards assets for institutional investors, managing trillions of dollars through its State Street Global Advisors (SSGA) division, which is renowned for launching the first U.S. exchange-traded fund (ETF), the SPDR S&P 500 ETF (SPY), in 1993. The company provides a range of services including investment management, research, trading, and data analytics, catering mostly to institutional clients like pension funds, endowments, and mutual funds. With a focus on financial infrastructure and innovation, State Street has positioned itself as a key backbone in the global investment ecosystem.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.79B |
| 2 |
Truist Financial
TFC
|
+$1.36B |
| 3 |
Alibaba
BABA
|
+$1.05B |
| 4 |
ServiceNow
NOW
|
+$945M |
| 5 |
Las Vegas Sands
LVS
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$2.96B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$1.4B |
| 3 |
Cummins
CMI
|
+$607M |
| 4 |
VIAB
Viacom Inc. Class B
VIAB
|
+$414M |
| 5 |
RTX Corp
RTX
|
+$402M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.83% |
| 2 | Financials | 15.11% |
| 3 | Healthcare | 13.45% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Verrica Pharmaceuticals
VRCA
$89.7M
| $3.57M | ﹤0.01% |
22,452
+1,609
| +8% | +$237K |
|
|
JNCE
2902
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $3.57M | ﹤0.01% |
408,691
-11,986
| -3% | -$64.8K |
|
|
MRSN
2903
DELISTED
Mersana Therapeutics
MRSN
| $3.56M | ﹤0.01% |
24,827
+841
| +4% | +$61.5K |
|
2904
Spyre Therapeutics
SYRE
$9.06B
| $3.55M | ﹤0.01% |
18,592
+1,324
| +8% | +$260K |
|
2905
KVH Industries
KVHI
$151M
| $3.54M | ﹤0.01% |
318,111
+19,342
| +6% | +$205K |
|
2906
Xeris Biopharma Holdings
XERS
$1.53B
| $3.53M | ﹤0.01% |
500,401
+33,950
| +7% | +$280K |
|
2907
TotalEnergies
TTE
$195B
| $3.52M | ﹤0.01% |
63,730
+968
| +2% | +$51.2K |
|
|
UBX
2908
DELISTED
Unity Biotechnology
UBX
| $3.52M | ﹤0.01% |
48,832
+6,357
| +15% | +$448K |
|
2909
Arq
ARQ
$97.4M
| $3.52M | ﹤0.01% |
334,916
+5,466
| +2% | +$65.3K |
|
2910
Willis Lease Finance
WLFC
$1.16B
| $3.51M | ﹤0.01% |
178,662
+7,566
| +4% | +$147K |
|
2911
Reading International Class A
RDI
$33.2M
| $3.51M | ﹤0.01% |
313,445
+5,384
| +2% | +$60.1K |
|
|
FNHC
2912
DELISTED
FedNat Holding Company Common Stock
FNHC
| $3.49M | ﹤0.01% |
210,092
+4,801
| +2% | +$71.7K |
|
|
PKD
2913
DELISTED
Parker Drilling Company
PKD
| $3.48M | ﹤0.01% |
154,590
+3,241
| +2% | +$62.6K |
|
2914
First Northwest Bancorp
FNWB
$106M
| $3.47M | ﹤0.01% |
191,605
+11,156
| +6% | +$196K |
|
|
RYZ
2915
Ryerson Holding Corp
RYZ
$1.44B
| $3.47M | ﹤0.01% |
293,586
+17,996
| +7% | +$178K |
|
|
PTVCB
2916
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
| $3.46M | ﹤0.01% |
215,272
+3,474
| +2% | +$56.6K |
|
|
CLCT
2917
DELISTED
Collectors Universe
CLCT
| $3.45M | ﹤0.01% |
149,744
+3,150
| +2% | +$84.3K |
|
|
SPNE
2918
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $3.45M | ﹤0.01% |
287,353
+14,537
| +5% | +$177K |
|
|
REV
2919
DELISTED
Revlon, Inc.
REV
| $3.42M | ﹤0.01% |
159,755
-252
| -0.2% | -$6.07K |
|
2920
iShares Russell Mid-Cap ETF
IWR
$57.7B
| $3.41M | ﹤0.01% |
57,165
-5,071
| -8% | -$291K |
|
|
AKTS
2921
DELISTED
Akoustis Technologies Inc
AKTS
| $3.41M | ﹤0.01% |
425,919
+40,339
| +10% | +$315K |
|
|
BRT
2922
BRT Apartments
BRT
$266M
| $3.39M | ﹤0.01% |
197,462
+14,455
| +8% | +$243K |
|
|
CBIO
2923
Crescent Biopharma
CBIO
$620M
| $3.39M | ﹤0.01% |
6,402
-263
| -4% | -$142K |
|
2924
eGain
EGAN
$203M
| $3.37M | ﹤0.01% |
425,967
+25,375
| +6% | +$196K |
|
2925
Foster
FSTR
$397M
| $3.37M | ﹤0.01% |
174,096
+8,517
| +5% | +$166K |
|
Similar funds
State Street's Q4 2019 Portfolio in Review
As of Q4 2019, State Street held 3,899 positions worth $1.46T, up 8.8% from $1.34T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 4.8%. State Street opened 94 new positions and exited 92, leaving the 3,899-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- State Street's largest Q4 2019 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 98,000 shares worth $114M.
- State Street added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.79B increase.
- State Street's biggest Q4 2019 reduction was Cummins, cutting an estimated $607M.
- State Street fully exited Celgene Corp in Q4 2019, selling an estimated $2.96B.
- State Street's ten largest holdings make up 18% of its $1.46T portfolio in Q4 2019.
- State Street opened 94 new positions and closed 92 in Q4 2019.
- State Street's portfolio value rose 8.8% quarter-over-quarter to $1.46T.
Based on State Street's 13F filing for Q4 2019, filed 6 Feb 2020.